𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial

✍ Scribed by Robert J. Motzer; Ethan Dmitrovsky; Wilson H. Miller Jr.; William P. Tong; Dean F. Bajorin; Howard I. Scher; George J. Bosl


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
523 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II trial of paclitaxel in refrac
✍ Alan B. Sandler; Antonios Cristou; Susan Fox; Stephen D. Williams; Craig R. Nich πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

over 24 hours every 21 days without growth factor support. The median age of the patients was 32.5 years (range, 18-49 years). The testis was the primary site of Genitourinary Oncology Program, Indiana Unitumor for 13 patients (72%) and the tumor was extragonadal in 5 patients (28%).

Hyperthermia for the treatment of patien
✍ RΓΌdiger Wessalowski; Heidi Kruck; Hildegard Pape; Thomas Kahn; Reinhart Willers; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 3 views

waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du Β¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the